Financhill
Back

Amicus Therapeutics Quote, Financials, Valuation and Earnings

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
44

FOLD
Amicus Therapeutics

Last Price:
$9.81
Seasonality Move:
5.47%

7 Day Trial

ALL ACCESS PASS

$ 7

The AI Energy Miracle

Details Here.

Amicus Therapeutics Price Quote

$9.81
+0.01 (+0.82%)
(Updated: December 21, 2024 at 5:26 AM ET)

Amicus Therapeutics Key Stats

Sell
44
Amicus Therapeutics (FOLD) is a Sell

Day range:
$9.60 - $9.88
52-week range:
$9.02 - $14.57
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.02
P/B ratio:
16.38%

Volume:
3.5M
Avg. volume:
2.6M
1-year change:
-23.68%
Market cap:
$2.9B
Revenue:
$399.4M
EPS:
$-0.34

How Much Does Amicus Therapeutics Make?

Data Unavailable

Is Amicus Therapeutics Growing As A Company?

Data Unavailable

Amicus Therapeutics Stock Price Performance

What Is Amicus Therapeutics 52-Week High & Low?

Amicus Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Amicus Therapeutics?

Data Unavailable

Is Amicus Therapeutics Cash Flow Positive?

Data Unavailable

Amicus Therapeutics Return On Invested Capital

Data Unavailable

Amicus Therapeutics Earnings Date & Stock Price

Amicus Therapeutics Competitors

  • Who Are Amicus Therapeutics's Competitors?
    Below is a list of companies who compete with Amicus Therapeutics or are related in some way:
    • Alnylam Pharmaceuticals Inc (ALNY)
    • Immuneering Corp (IMRX)
    • Insmed Inc (INSM)
    • Ionis Pharmaceuticals Inc (IONS)
    • Tonix Pharmaceuticals Holding Corp (TNXP)

Amicus Therapeutics Dividend Yield

Data Unavailable

Amicus Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 91.02%
Revenue: 36.73% 4.86%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable